Literature DB >> 17381670

Hyperprolactinemia and amenorrhea associated with olanzapine normalized after addition of aripiprazole.

J Wolf1, U Fiedler.   

Abstract

Hyperprolactinemia is a frequent side-effect in the use of atypical antipsychotics. The propensity to induce hyperprolactinemia is highly substance dependent and hyperprolactinemia is not always associated with clinical side-effects. We report a case in which hyperprolactinemia and amenorrhea under the treatment with olanzapine gets normalized after the addition of aripiprazole.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17381670     DOI： 10.1111/j.1365-2710.2007.00806.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN： 0269-4727            Impact factor:   2.512


  4 in total

Review 1.  Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Authors:  Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

Review 2.  Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review.

Authors:  Frank M C Besag; Michael J Vasey; Iffah Salim
Journal:  CNS Drugs       Date:  2021-04-20       Impact factor: 5.749

3.  The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study.

Authors:  Kojiro Hashimoto; Norio Sugawara; Masamichi Ishioka; Kazuhiko Nakamura; Norio Yasui-Furukori
Journal:  Neuropsychiatr Dis Treat       Date:  2014-08-22       Impact factor: 2.570

Review 4.  Weight gain and metabolic issues of medicines used for bipolar disorder.

Authors:  Andrea Fagiolini; K N Roy Chengappa
Journal:  Curr Psychiatry Rep       Date:  2007-12       Impact factor: 8.081
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.